Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept use

Inflammation in Complicated Pregnancy and Its Outcome

(2016) Ram Kalagiri et al.   AMERICAN JOURNAL OF PERINATOLOGY

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

(2016) Carina Götestam Skorpen et al.   ANNALS OF THE RHEUMATIC DISEASES

Low Risk of Birth Defects for Infants Whose Mothers Are Treated With Anti–Tumor Necrosis Factor Agents During Pregnancy

(2016) Gabriella Bröms et al.   Clinical Gastroenterology and Hepatology

Placental tumor necrosis factor-α protein expression during normal human gestation

(2016) Jayasri Basu et al.   Journal of Maternal-Fetal & Neonatal Medicine

Reproductive trends in females with inflammatory joint disease

(2016) Marianne Wallenius et al.   BMC Pregnancy and Childbirth

Secular trends of pregnancies in women with inflammatory connective tissue disease

(2015) Marianne Wallenius et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

State of the art: Reproduction and pregnancy in rheumatic diseases

(2015) Monika Østensen et al.   AUTOIMMUNITY REVIEWS

Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study

(2015) Corinna Weber-Schoendorfer et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies

(2015) Peter C. Austin et al.   STATISTICS IN MEDICINE

On regression adjustment for the propensity score

(2014) S. Vansteelandt et al.   STATISTICS IN MEDICINE

Rheumatoid arthritis and outcomes in first and subsequent births based on data from a national birth registry

(2013) Marianne Wallenius et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: A prospective, comparative, observational study

(2013) Orna Diav-Citrin et al.   REPRODUCTIVE TOXICOLOGY

Biologic therapies and pregnancy: the story so far

(2013) K. L. Hyrich et al.   RHEUMATOLOGY

Tumor necrosis factor-α inhibitor therapy and fetal risk: A systematic literature review

(2013) Renée M Marchioni   WORLD JOURNAL OF GASTROENTEROLOGY

Treatment with biologics of pregnant patients with rheumatic diseases

(2011) Monika Østensen et al.   CURRENT OPINION IN RHEUMATOLOGY

Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study

(2010) M. Nørgaard et al.   JOURNAL OF INTERNAL MEDICINE

Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant's serum

(2009) A Murashima et al.   ANNALS OF THE RHEUMATIC DISEASES

Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: Results of a national prospective study

(2009) Ya��l A. de Man et al.   ARTHRITIS AND RHEUMATISM

Use of Stabilized Inverse Propensity Scores as Weights to Directly Estimate Relative Risk and Its Confidence Intervals

(2009) Stanley Xu et al.   VALUE IN HEALTH